✦ LIBER ✦

Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care

✍ Scribed by Lee, Jung Ah; Sunwoo, Sung; Kim, Young Sik; Oh, Han Jin; Kang, Hee-Cheol; Park, Kyung-Chae; Sin, Dong Hyuk; Lee, Sang Yeoup; Yang, Yun Jun; Yu, Byung Yeon; Kim, Chul-Min

Book ID: 120387801
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 694 KB
Volume: 29
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2013.802683

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rosuvastatin produces significantly grea

Rosuvastatin produces significantly greater reductions in low-density lipoprotein cholesterol and more patients achieve treatment goals compared with simvastatin

✍ Ian Hamilton-Craig; Ernst Schaefer; Michel Farnier; Michael Koren; Harry Southwo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Achieving Low-Density Lipoprotein Choles

Achieving Low-Density Lipoprotein Cholesterol Goals in High-Risk Patients in Managed Care: Comparison of Rosuvastatin, Atorvastatin, and Simvastatin in the SOLAR Trial

✍ Insull, William; Ghali, Jalal K.; Hassman, David R.; Ycas, Joseph W.; Gandhi, Sa 📂 Article 📅 2007 🏛 Mayo Clinic 🌐 English ⚖ 108 KB

The Low-Density Lipoprotein Cholesterol-

The Low-Density Lipoprotein Cholesterol-Lowering Effect of Pravastatin and Factors Associated with Achieving Targeted Low-Density Lipoprotein Levels in an African-American Population

✍ Dr. Pang H. Chong; Dr. Pamala J. Tzallas-Pontikes; Dr. John D. Seeger; Dr. Thoma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Effects of Ezetimibe, Simvastatin, and E

Effects of Ezetimibe, Simvastatin, and Ezetimibe/Simvastatin on Apolipoprotein B, Low-Density Lipoprotein Cholesterol, and Non–High-Density Lipoprotein Cholesterol Targets in Patients with Primary Hypercholesterolemia†

✍ John R. Guyton; Michel Farnier; Erin H. Jensen; Adam B. Polis; Amy O. Johnson-Le 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 58 KB

Efficacy and safety of ezetimibe co-admi

Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease

✍ J. M. CRUZ-Fernández; G. V. Bedarida; J. Adgey; C. Allen; A. O. Johnson-Levonas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Low high-density lipoprotein cholesterol

Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol

✍ Manabu Ogita, Katsumi Miyauchi, Tadashi Miyazaki, Ryo Naito… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 213 KB